{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Opko Health, Inc."},"Symbol":{"label":"Symbol","value":"OPK"},"Address":{"label":"Address","value":"4400 BISCAYNE BOULEVARD, MIAMI, Florida, 33137, United States"},"Phone":{"label":"Phone","value":"+1 305 575-4100"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs."},"CompanyUrl":{"label":"Company Url","value":"https://www.opko.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jane H. Hsaio","title":"Vice Chairman & Chief Technical Officer"},{"name":"Phillip Frost","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}